BCL2 and prostate cancer: Experiments in LNCaP cells (androgen-responsive prostate cancer) have shown that Bcl-2 is essential for both the survival of androgen-independent prostate cancer cells and the transition of prostate cancer cells from androgen-dependent to androgen-independent states (Lin et al., 2007).